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ABSTRACT
Background: Atopic dermatitis is a chronically relapsing inflammatory skin disease. Animal models induced
by relevant allergens play a very important role in the elucidation of the disease. The patients with atopic der-
matitis are highly sensitized with mite allergens such as Dermatophagoides farinae (Df). Therefore, in the pre-
sent study, we tried to develop a novel model for atopic dermatitis by repeated application with Df extract oint-
ment.
Methods: Df extract ointment was repeatedly applied to the back of NCNga mice together with barrier disrup-
tion. Atopic dermatitis-like skin lesions were evaluated by dermatitis scores, skin histology and immunological
parameters. The effect of corticosteroid and calcineurin inhibitor was also examined.
Results: Repeated application of Df extract ointment caused rapid increase in dermatitis scores. Clinical (skin
dryness, erythema, edema and erosion) and histological symptoms (dermal and epidermal thickening, hyperk-
eratosis, parakeratosis and inflammatory cell infiltration) in this model were very similar to those in human
atopic dermatitis. Serum total and Df-specific IgE levels were elevated in this model compared with normal
mice, and draining lymph node cells isolated from the mice that exhibited dermatitis produced significant
amounts of interleukin-5, interleukin-13 and interferon-γ after re-stimulation with Df. Furthermore, current first-
line drugs for the treatment of human atopic dermatitis, corticosteroid and tacrolimus ointments, were effective
against the clinical and histological symptoms in this model.
Conclusions: These results suggest that the model we have established is useful for not only elucidating the
pathogenesis of atopic dermatitis but also for evaluating therapeutic agents.
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INTRODUCTION
Atopic dermatitis is a chronically relapsing inflamma-
tory skin disease accompanied by severe itching. It is
a major public health problem worldwide occurring at
rates of 10―20% in children and 1―3% in adults.1 Preva-
lence of atopic dermatitis has increased in recent
years, but the pathophysiology of this condition is
only partly understood. In addition, although corti-
costeroids and calcineurin inhibitors are used in the
treatment of atopic dermatitis,2 there remains a need
for topical anti-inflammatory drugs without side ef-
fects.
Recently, several models have been developed for
atopic dermatitis in mice: a spontaneously developed
dermatitis model in NCNga and its sub-strain mice
under non-specific pathogen free (SPF) conditions,3-5
a hapten-induced dermatitis model in NCNga mice
under SPF conditions,6 and a dermatitis model in HR-
1 mice using a diet low in magnesium and zinc.7
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These models fulfill some of the features of atopic
dermatitis, but differ from human atopic dermatitis in
their pathogenesis. For example, spontaneous derma-
titis in NC mice is thought to be induced by Myocop-
tes musculinus and Myobia musculi, which infest ro-
dents, but not humans.4,5 The triggers of hapten-
induced dermatitis and dermatitis in HR-1 mice are
also not relevant.
Patients with atopic dermatitis are highly sensi-
tized to house dust mite (HDM) allergens based on
the positive results from radioallergosorbent, scratch
and patch tests.8-10 A major species of HDM in Japan
is Dermatophagoides farinae (Df), and its body and fe-
ces are well known as major environmental aller-
gens.11 Thus, we considered Df extract to be relevant
for the induction of dermatitis, and examined the
characteristic features of Df extract-induced dermati-
tis in NCNga mice. Previously, Matsuoka et al.12 re-
ported that Df extract has the ability to induce atopic
dermatitis-like skin lesion in mice when applied as a
Df extract suspension. However, the onset of dermati-
tis in their model was relatively slow. We considered
the reason for the slow onset to be the rapid disap-
pearance of allergens from the back of mice and hy-
pothesized that Df extract ointment would remain
longer than Df extract suspension. This led us to use
Df extract ointment to achieve a rapid onset of the
skin lesion. Repeated application with Df extract oint-
ment together with barrier disruption could induce
atopic dermatitis-like skin lesions in NCNga mice.
The dermatitis caused by Df extract ointment was ob-
served to be significant 2 weeks after the first applica-
tion. Clinical, immunological and histological features
of this model were similar to those of human atopic
dermatitis. We also confirmed the efficacy of corti-
costeroid and tacrolimus ointments against this
model. These results indicate that the Df extract
ointment-induced dermatitis model in NCNga mice
is useful for elucidating the pathogenesis of atopic
dermatitis and also for evaluating therapeutic agents.
METHODS
MICE
Female NCNga mice were purchased from Charles
River Japan (Yokohama, Japan). These mice were all
housed under conditions of controlled temperature
(20―26℃), humidity (30―70%) and lighting (lights on
from 08:00 to 20:00). Food and tap water were pro-
vided ad libitum. All mice were 10―15 weeks of age.
The animal experiments in this study were approved
by the Animal Care and Use Committee of Shionogi
Research Laboratories.
DRUGS
Betamethasone dipropionate ointment, 0.064%,
(Rinderon®-DP, Shionogi, Osaka, Japan) and
tacrolimus ointment, 0.1%, (Protopic®, Fujisawa,
Osaka, Japan) were used in this study.
PREPARATION OF DF EXTRACT OINTMENT
Df were cultured, then the mite bodies were sepa-
rated from their feces and culture media by flotation
on saturated water solution of sodium chloride.13 The
Df body (Dfb) extract was prepared according to the
method of Yamaguchi et al..14 In brief, floating mites
were pooled and their bodies were homogeneously
suspended in phosphate-buffered saline using an ag-
ate mortar and pestle. The suspension was stirred
overnight, followed by centrifugation. The superna-
tant was dialyzed and lyophilized. The freeze-dried
extracts were mixed with hydrophilic petrolactum
(Maruishi, Osaka, Japan) at a concentration of 5 mg
Dfb extract1 g hydrophilic petrolatum, referred to
as Dfb ointment.
INDUCTION OF DERMATITIS
Mice were anesthetized with ether and their hair on
the upper back was shaved with a clipper and a
shaver. Elicitation was performed by topical applica-
tion of 100 mg Dfb ointment or ointment base (hy-
drophilic petrolatum) on the shaved dorsal skin and
both surfaces of each ear. Barrier disruption was
achieved by 150 µL of 4% sodium dodecyl sulfate
treatment on the shaved dorsal skin and both sur-
faces of each ear 3 hours before the Dfb ointment ap-
plication. These procedures were repeated twice a
week. Mice were assigned to one of four groups at
the beginning of the experiment: Group A, barrier
disruption and Dfb; Group B, Dfb ointment without
barrier disruption; Group C, barrier disruption and
ointment base; and Group D, ointment base without
barrier disruption. Following the last antigen chal-
lenge on day 25 after the first elicitation, these mice
were sacrificed on day 28, and immunological and
histological changes were investigated.
EVALUATION OF SKIN LESION
The severity of dermatitis was evaluated once a week,
just before each elicitation. The development of 1)
erythemahemorrhage, 2) scarringdryness, 3)
edema, 4) excoriationerosion was scored as 0
(none), 1 (mild), 2 (moderate) and 3 (severe). The
sum of the individual scores was taken as the derma-
titis score.
MEASUREMENT OF SERUM TOTAL IgE AND
SPECIFIC IgE TO Dfb
Sera were collected by drawing blood from the heart
under ether anesthesia. The concentration of total
IgE was measured using a mouse IgE EIA kit
(Yamasa, Tokyo, Japan), according to the manufac-
turer’s protocol. Specific IgE to Dfb was evaluated us-
ing passive cutaneous anaphylaxis (PCA).15 Briefly,
female Sprague-Dawley rats (Charles River Japan,
Yokohama, Japan), which were used as recipients,
were sensitized with intradermal injection of 50 µL of
serially diluted sera on shaved dorsal skin. They were
Df-induced Atopic Dermatitis Model
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Fig. 1 Development of atopic dermatitis-like skin lesions after Df applica-
tion in NC/Nga mice. Elicitation was performed by topical application of 100 
mg Dfb ointment or ointment base (hydrophilic petrolatum) on the shaved 
dorsal skin and both surfaces of each ear. Barier disruption was achieved 
by 150 μL of 4% sodium dodecyl sulfate treatment on the shaved dorsal 
skin and both surfaces of each ear 3 hours before the Dfb ointment 
application. These procedures were repeated twice a week. Mice were as-
signed to one of four groups: Group A, barier disruption and Dfb ointment 
(closed circles); Group B, Dfb ointment (closed triangles); Group C, barier 
disruption and ointment base (open circles); and Group D, ointment base 
(open triangles). Each data represents the mean ± S.E. of 5― 8 mice. 
＊p＜0.05 when compared with each control group (Wilcoxon test).
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challenged 24 hours later by intravenous injection of
0.5 ml saline containing 1 mg Dfb and 5 mg Evans
blue. Thirty minutes later, the animals were sacri-
ficed by exsanguination under deep anesthesia. The
pigmented area was measured from the inner side of
the skin. An area more than 5 mm in diameter was
regarded as a positive reaction, and the antibody titer
was determined.
MEASUREMENT OF CYTOKINE LEVELS BY AX-
ILLARY LYMPH NODE CELLS
Axillary lymph nodes were isolated, and a single cell
suspension was prepared. The lymph node cells (5 ×
106 cells) were re-stimulated with 10 µgml of Dfb in
a 24-well flat-bottom microplate at 37℃ for 24
hours. After the incubation period, the culture super-
natants were collected. The amount of interleukin
(IL)-5, IL-13, IL-4 and interferon (IFN)-γ in the culture
supernatant was determined using a murine ELISA
kit (Genzyme, Minneapolis, Minnesota, USA).
HISTOLOGICAL OBSERVATION OF THE SKIN
Portions of the dorsal skin were fixed with 10% neu-
tral formalin, embedded in paraffin and sectioned at 4
µm. Sections were stained with hematoxylin-eosin. In
addition, for the detection of mast cells and eosino-
phils, sections were stained with toluidine blue and
direct first scarlet, respectively. The number of mast
cells was counted from the epidermis to the pannicu-
lus adiposus under a microscope with an eyepiece
squared micrometer at a magnification of ×400.
EFFECT OF TACROLIMUS OINTMENT AND
CORTICOSTEROID OINTMENT ON ESTAB-
LISHED DERMATITIS
NCNga mice having demonstrated dermatitis with a
score of over 3 for 2 weeks were used. Each ointment
at a weight of 100 mg, was applied to the shaved dor-
sal skin and both surfaces of each ear twice a week.
The dermatitis was scored on day 0, 1, 4, 5, 7, 8, 11,
12 and 13 after the start of each treatment. On day 13,
skin from the upper back was excised and fixed with
10% neutral formalin, and the sections were stained as
described above.
STATISTICAL ANALYSIS
Data were expressed as the means ± S.E. The statisti-
cal significance of differences was assessed by Stu-
dent’s t -test or Dunnet’s test except for the dermatitis
score, which was assessed by the Wilcoxon test or
Yamamoto M et al.
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Fig. 2 Macroscopic features of atopic dermatitis-like skin lesions in 
NC/Nga mice on day 28. Normal mice, ointment base with barier 
disruption-treated mice and Dfb ointment with barier disruption-treated 
mice.
Normal mice
Ointment base with barrier disruption-treated mice
Dfb ointment with barrier disruption-treated mice
Steel’s test. P-values less than 0.05 were considered
to be statistically significant.
RESULTS
DEVELOPMENT OF ATOPIC DERMATITIS-LIKE
SKIN LESION
To establish the Dfb-induced dermatitis model in
NCNga mice, we repeatedly applied Dfb ointment to
the dorsal skin. As shown in Figure 1, the dermatitis
scores of Group A (barrier disruption + Dfb oint-
ment) increased rapidly and became significant 2
weeks after the first elicitation. However, in Group B
(Dfb ointment without barrier disruption), skin le-
sions were minimally observed. After the repeated ap-
plication of Dfb ointment, skin dryness occurred first,
followed by mild erythema, hemorrhage and edema.
Finally, the skin became thick and severe erythema,
hemorrhage, edema, scarring, erosion and excoria-
tion were observed (Fig. 2). The application of Dfb
ointment after barrier disruption once a week did not
cause significant dermatitis (data not shown). In
Group A (barrier disruption + Dfb ointment), scratch-
ing behavior of the back and ears with hind paws was
also observed (data not shown). These symptoms
could not be detected in Group C (barrier disrup-
tion + ointment base) and D (ointment base without
barrier disruption). Therefore, we decided that the
procedure used for Group A, i.e. barrier disruption
and Dfb ointment twice a week, was optimal for the
induction of dermatitis in NCNga mice.
HISTOLOGICAL EVALUATION OF THE LE-
SIONAL SKIN
In a comparison of histological changes of the dorsal
skin on day 28 after the first elicitation with Dfb oint-
ment or ointment base with barrier disruption, it was
found that lesional skin showed a significant thicken-
ing of the dermis and epidermis, hyperkeratosis, and
parakeratosis in the Dfb ointment-treated group
(Figs. 3A, B). In addition, the epidermis deepened
into the upper dermis. An increased number of der-
mal inflammatory cells including mast cells (Figs. 3C,
D) and eosinophils (Figs. 3E, F) were also observed.
The number of total and degranulated mast cells in
the Dfb ointment-treated group was much higher
than those in the ointment base-treated group and
normal mice (Fig. 4). Most of the mast cells in the up-
per dermis were degranulated.
SERUM TOTAL IgE AND SPECIFIC IgE TO Dfb
Serum levels of total IgE and specific IgE to Dfb in
NCNga mice on day 28 after the first elicitation were
Df-induced Atopic Dermatitis Model
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Fig. 3 Histological changes of the dorsal skin after Df application in NC/Nga 
mice. The dorsal skin of ointment base with barier disruption-treated mice (A, C, 
E) and Dfb ointment with barier disruption-treated mice (B, D, F) were extirpated 
on day 28 and stained with hematoxylin-eosin (A, B), toluidine blue (C, D) and di-
rect first scarlet (E, F). A and B are of the original magnification ×100, C―F of the 
original magnification ×400.
Ointment Base
A B
C D
E F
Dfb ointment
Fig. 4 The number of total (A) and degranulated (B) mast cels in normal, 
ointment base with barier disruption-treated (Base) and Dfb ointment with 
barier disruption-treated (Dfb) mice. Mast cels were counted from the epi-
dermis to the panniculus adiposus under a microscope with an eyepiece 
squared micrometer at a magnification of ×400. Each data represents the 
mean ± S.E. of 5―8 mice. ＊p＜0.05 when compared with ointment base 
with barier disruption-treated group (Student's t test).
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Fig. 5 Serum levels of total IgE (A) and specific IgE to Dfb (B) in normal, 
ointment base with barier disruption-treated (Base) and Dfb ointment with 
barier disruption-treated (Dfb) mice on day 28. Total IgE data represents 
the mean ± S.E. of 5―8 mice. ＊p＜0.05 when compared with ointment 
base with barier disruption-treated group (Student’ st test).
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Fig. 6 Cytokine levels produced by axilary lymph node cels in normal and Dfb ointment 
with barier disruption-treated mice. IFN-γ, IL-5 and IL-13 levels were examined in the cul-
ture supernatants after 24 hours of re-stimulation of lymph node cels with Dfb. Each data 
represent the mean ± S.E. of 5 mice. ＊ p＜ 0.05 when compared with normal mice 
(Student’ st test).
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examined. The total IgE levels of mice in the Dfb
ointment-treated group were significantly elevated
compared with the normal and ointment base-treated
groups (Fig. 5A). Specific IgE to Dfb were highly in-
duced in the Dfb ointment-treated group, but not de-
tected in the normal and ointment base-treated
groups (Fig. 5B).
CYTOKINE PRODUCTION IN AXILLARY LYMPH
NODE CELLS
We examined IL-5, IL-13, IL-4 and IFN-γ production of
axillary lymph node cells obtained from the Dfb
ointment-treated and normal mice after 48-hour incu-
bation with Dfb. Lymph node cells from the Dfb
ointment-treated mice showed marked elevation of
IL-5, IL-13 and IFN-γ levels compared with those from
normal mice (Fig. 6). IL-4 in the culture supernatant
of lymph node cells from both the Dfb ointment-
treated and normal mice were below the detection
limit (data not shown).
EFFECT OF TACROLIMUS OINTMENT AND
CORTICOSTEROID OINTMENT ON ESTAB-
LISHED DERMATITIS
NCNga mice having demonstrated dermatitis with
scores of over 3 for 2 weeks were used. As shown in
the non-treated group, the dermatitis score did not
decrease for at least two weeks even after application
of barrier disruption and Dfb ointment was stopped.
In the betamethasone dipropionate ointment-and
tacrolimus ointment-treated groups, the dermatitis
scores clearly decreased immediately after drug ap-
plication (day 1), and significant suppression was ob-
served from day 1 to day 13 in both groups compared
Df-induced Atopic Dermatitis Model
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Fig. 7 Efect of betamethasone dipropionate ointment and tacrolimus oint-
ment on established dermatitis model. NC/Nga mice having demonstrated der-
matitis with scores over 3 for two weeks were used. Ointment base (open 
circles), betamethasone dipropionate ointment (closed circles) and tacrolimus 
ointment (closed triangles) at a weight of 100 mg were applied to shaved dorsal 
skin and both surfaces of each ear twice a week. No medication was applied in 
the Non-treated group (closed diamonds). Each data represents the mean ± 
S.E. of 9 ― 10 mice. ＊p＜0.05, ＊＊p＜0.01 when compared with non-treated 
group. ＃p＜0.05, ＃＃p＜0.01 when compared with the ointment base-treated 
group (Steel’ stest).
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with ointment base-treated group (Fig. 7).
Histologically, in the groups treated with be-
tamethasone dipropionate ointment and tacrolimus
ointment, epidermal thickening and infiltration of in-
flammatory cells in the dermis were very slight com-
pared with those in the non-treated and ointment
base-treated groups (Fig. 8). Betamethasone
dipropionate ointment-treated mice showed signifi-
cant reduction of the number of total and degranu-
lated mast cells in the skin (Fig. 9).
DISCUSSION
In the present study, we demonstrated that repeated
application with Df extract ointment induced atopic
dermatitis-like skin lesions in NCNga mice. Interest-
ingly, the dermatitis score remained high for at least
2 weeks after application of Dfb ointment was
stopped. This is very convenient for evaluation of the
efficacy of topically applied drugs, because there
would be no question about the possibility for an in-
teraction between the drug and the antigen. Indeed,
we found that corticosteroid and tacrolimus oint-
ments that are used for the treatment of human
atopic dermatitis exhibited significant suppressive ef-
fects on the skin lesions. These findings strongly sug-
gest that this model can be useful for not only eluci-
dating the pathogenesis of atopic dermatitis but also
for the evaluating novel therapeutic agents.
Atopic dermatitis is a chronically relapsing inflam-
matory skin disease and a major public health prob-
lem worldwide. Patients with atopic dermatitis are
highly sensitized to HDM allergens. Thus, HDM al-
lergens are considered to be common environmental
allergens causing atopic dermatitis. As Df is a major
species of HDM in Japan,11 it would be logical to use
Df to develop an atopic dermatitis model as a relevant
antigen.
Repeated application with Df extract ointment
could induce atopic dermatitis-like skin lesions in
NCNga mice. Clinical symptoms appearing in this
model began with skin dryness, followed by mild
erythema, hemorrhage and edema. Finally, the skin
became thick and severe erythema, hemorrhage,
edema, scarring, erosion and excoriation were ob-
served. Histologically, the lesional skin showed sig-
nificant thickening of the dermis and epidermis, hy-
perkeratosis and parakeratosis. These changes were
associated with an increased number of dermal in-
flammatory cells containing mast cells, eosinophils
and lymphocytes. Both clinical and histological symp-
toms in our model were very similar to those in hu-
man atopic dermatitis.16,17 Scratching behavior, one
of the most important symptoms in atopic dermatitis,
was also observed in our model. Df extract-induced
dermatitis in mice was previously reported by Matu-
soka et al..12 They used Df extract suspension to in-
duce dermatitis, but its onset was relatively slow. In
our preliminary experiment, repeated application
with Df extract suspension revealed only minimal in-
duction of dermatitis (data not shown). We hypothe-
sized that the slow onset or failure to induce dermati-
tis was due to the quick disappearance of allergen
from the back of mice and that Df extract ointment
would remain longer than Df extract suspension.
Yamamoto M et al.
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Fig. 8 Histological changes of the dorsal skin in the group treated with be-
tamethasone dipropionate ointment and tacrolimus ointment. The dorsal 
skin of non-treated mice (A), ointment base-treated mice (B), betametha-
sone dipropionate ointment-treated mice (C) and tacrolimus ointment-
treated mice (D) were stained with hematoxylin-eosin. Original magnifica-
tion ×100 for al photos.
A B
C D
Therefore, to achieve a rapid onset of the skin lesion,
we decided to use Df extract ointment to induce der-
matitis. As expected, Df extract ointment-induced
atopic dermatitis-like skin lesion displayed a rapid on-
set and a chronically sustained course.
Previous studies on atopic dermatitis suggest that
skin lesions accompanied by topical eosinophilia and
systemic IgE elevation are associated with Th2 type
cytokine (IL-4, IL-5 and IL-13) expression. Indeed,
predominant expression of Th2 cytokines were con-
firmed in both acute and chronic lesions of atopic der-
matitis compared with the uninvolved skin of patients
with atopic dermatitis or normal subjects.18,19 How-
ever, recent studies have demonstrated that the ex-
pression of IFN-γ was more predominant than that of
IL-4 in chronic skin lesions in atopic dermatitis, while
the levels of IL-5 and IL-13 still remained high.20
Therefore, the theory that activation of Th2 cells in
the acute phase of atopic dermatitis, followed by both
Th1 and Th2 activation leads to chronic dermatitis is
currently considered to be plausible. In the present
study, draining lymph node cells isolated from mice
that exhibit chronic skin lesions produced significant
amounts of IL-5, IL-13 and IFN-γ after re-stimulation
with Df in vitro. Moreover, levels of serum total and
Df-specific IgE were elevated in mice exhibiting der-
matitis compared with normal mice. These results
suggest that both Th1 and Th2 cells are involved in
the development of chronic dermatitis in our model
as well as in human atopic dermatitis. The expression
of Th1 and Th2 cytokines in skin lesions needs to be
clarified in the future.
Our dermatitis model established in the present
study offers the advantage of allowing evaluation of
topically applied drugs, because the established skin
lesion in our model lasted for at least 2 weeks without
further topical application of allergen. In patients with
atopic dermatitis, itch-associated scratching damages
the skin and increases the inflammation, which in
turn increases the itching further.21,22 We observed
scratching behavior of mice at the sites of antigen ap-
plication in our model, and the established skin le-
sions were improved by cutting off hind toenails of
mice (data not shown). Therefore, the continuous
scratching behavior would maintain the dermatitis
without the further antigen application. Next, we in-
vestigated whether our model is available to evaluate
the efficacy of drugs currently used for the treatment
of human atopic dermatitis. The first-line drugs for
atopic dermatitis are corticosteroids.23 In addition,
tacrolimus ointment, launched in 1999 in Japan, is
particularly useful for skin lesions on the neck and
face.24 Tacrolimus ointment has been found to exhibit
potent inhibitory effects on spontaneously developed
dermatitis in NCNga mice, while corticosteroid oint-
ment has only marginal effects.25 Therefore, we ex-
Df-induced Atopic Dermatitis Model
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Fig. 9 Efect of betamethasone dipropionate ointment and 
tacrolimus ointment on total (A) and degranulated mast cels 
(B) in the skin of established dermatitis model. Mast cels 
were counted from epidermis to panniculus adiposus under 
a microscope with an eyepiece squared micrometer at a 
magnification of ×400. Each data represents the mean ± 
S.E. of 9―10 mice. ＊p＜0.05, ＊＊p＜0.01 when compared 
with the non-treated group. ＃p＜ 0.05, ＃＃p＜ 0.01 when 
compared with the ointment base-treated group (Dunnet’ s
test).
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amined the effect of betamethasone dipropionate
ointment, a steroid ointment, and tacrolimus oint-
ment on established dermatitis in our model. These
ointments applied twice a week rapidly and clearly re-
duced dermatitis scores, and the inhibitory effects
lasted through out the study. The efficacy of these
ointments on dermatitis scores was accompanied by
significant improvement of histological changes such
as epidermal thickening and infiltration of inflamma-
tory cells.
In conclusion, we developed a novel animal model
for atopic dermatitis by repeated application with Df
extract ointment in NCNga mice. All of the clinical,
histological, and immunological features in this
model were similar to the events observed in patients
with atopic dermatitis. Furthermore, we confirmed
the efficacy of corticosteroid and tacrolimus oint-
ments against this model. Therefore, it is suggested
that our model is useful for not only eludicating the
pathogenesis of atopic dermatitis but also for evaluat-
ing therapeutic agents.
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